Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 195

1.

Treatment outcome of multidrug-resistant tuberculosis among Vietnamese immigrants.

Ward HA, Marciniuk DD, Hoeppner VH, Jones W.

Int J Tuberc Lung Dis. 2005 Feb;9(2):164-9.

PMID:
15732735
2.

[Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].

Saito W, Nagayama N, Miyamoto M, Hara H, Suzuki J, Masuda K, Baba M, Tamura A, Nagai H, Akagawa S, Kawabe Y, Machida K, Kurashima A, Yotsumoto H.

Kekkaku. 2003 Oct;78(10):611-7. Japanese.

PMID:
14621568
4.

[Treatment results of rifampicin (RFP) resistant isoniazid (INH) susceptible tuberculosis, a hospital based study].

Yoshiyama T, Ogata H, Ito K, Aono A, Wada M.

Kekkaku. 2007 Feb;82(2):95-101. Japanese.

PMID:
17373318
5.

Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.

Park SK, Kim JH, Kang H, Cho JS, Smego RA Jr.

Int J Infect Dis. 2009 Mar;13(2):170-5. doi: 10.1016/j.ijid.2008.06.001. Epub 2008 Sep 2.

6.

Frequency of recurrence among MDR-tB cases 'successfully' treated with standardised short-course chemotherapy.

Migliori GB, Espinal M, Danilova ID, Punga VV, Grzemska M, Raviglione MC.

Int J Tuberc Lung Dis. 2002 Oct;6(10):858-64.

PMID:
12365571
7.

Treatment of multiple drug-resistant tuberculosis (MDR-TB) in Iran.

Mirsaeidi SM, Tabarsi P, Khoshnood K, Pooramiri MV, Rowhani-Rahbar A, Mansoori SD, Masjedi H, Zahirifard S, Mohammadi F, Farnia P, Masjedi MR, Velayati AA.

Int J Infect Dis. 2005 Nov;9(6):317-22. Epub 2005 Sep 23.

8.

[Treatment outcomes of multidrug-resistant tuberculosis--comparison between success and failure cases].

Shigetoh E, Murakami I, Yokosaki Y, Kurimoto N.

Kekkaku. 2001 Dec;76(12):723-8. Japanese.

PMID:
11806128
9.
10.

Efficacy and safety of kanamycin, ethionamide, PAS and cycloserine in multidrug-resistant pulmonary tuberculosis patients.

Prasad R, Verma SK, Sahai S, Kumar S, Jain A.

Indian J Chest Dis Allied Sci. 2006 Jul-Sep;48(3):183-6.

PMID:
18610675
11.
12.

Self-administered, standardized regimens for multidrug-resistant tuberculosis in South Korea.

Park SK, Lee WC, Lee DH, Mitnick CD, Han L, Seung KJ.

Int J Tuberc Lung Dis. 2004 Mar;8(3):361-8.

PMID:
15139476
13.

[The short-term and long-term treatment outcomes in patients with pulmonary tuberculosis positive for drug-resistant and sensitive strains].

Han JP, Sun SL, Li RZ, Zhang FS, Wang SC, Cheng J, Deng YF, Wang Y, Yu CB.

Zhonghua Jie He He Hu Xi Za Zhi. 2003 Feb;26(2):70-3. Chinese.

PMID:
12783654
14.

Impact of country of origin on drug-resistant tuberculosis among foreign-born persons in British Columbia.

Moniruzzaman A, Elwood RK, Schulzer M, FitzGerald JM.

Int J Tuberc Lung Dis. 2006 Aug;10(8):844-50.

PMID:
16898367
15.

[Multidrug resistant tuberculosis in Romania in the last years (2004-2007)--an extremely important social phenomenon].

Marica C, Didilescu C, Chiotan D, Galie N, Tănăsescu M, Popescu-Hagen M, Popa M.

Pneumologia. 2008 Oct-Dec;57(4):195-200. Romanian.

PMID:
19186681
16.

Failure of chemoprophylaxis with standard antituberculosis agents in child contacts of multidrug-resistant tuberculosis cases.

Sneag DB, Schaaf HS, Cotton MF, Zar HJ.

Pediatr Infect Dis J. 2007 Dec;26(12):1142-6.

PMID:
18043453
18.

Surveillance of drug-resistant tuberculosis in the state of Gujarat, India.

Ramachandran R, Nalini S, Chandrasekar V, Dave PV, Sanghvi AS, Wares F, Paramasivan CN, Narayanan PR, Sahu S, Parmar M, Chadha S, Dewan P, Chauhan LS.

Int J Tuberc Lung Dis. 2009 Sep;13(9):1154-60.

PMID:
19723407
19.

Ofloxacin in multidrug resistant tuberculosis.

Walwaikar PP, Morye VK, Gawde AS.

J Indian Med Assoc. 2003 Mar;101(3):210-2.

PMID:
14603981
20.

[Treatment outcome of patients with multidrug-resistant pulmonary tuberculosis during pregnancy].

Takashima T, Danno K, Tamura Y, Nagai T, Matsumoto T, Han Y, Ano H, Yoshida H, Kawahara K, Tsuyuguchi I.

Kekkaku. 2006 Jun;81(6):413-8. Japanese.

PMID:
16838679

Supplemental Content

Support Center